A critical advance in cancer study is emerging with the use of nanobodies to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in many kinds of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research